Comparison of three high-sensitivity cTnI immunoassays revealed an average between-method difference of 31.2% CV, with ADVIA Centaur XPT measuring higher values than Architect and Access methods.
Observational (n=2,833)
Yes
Are plasma cTnI concentration values comparable when measured with three different high-sensitivity methods in healthy volunteers and ED patients with suspected ACS?
Significant variations exist between different high-sensitivity troponin I assays, reinforcing the clinical necessity of using the same assay for serial patient monitoring.
BACKGROUND: The study aim is to compare cTnI values measured with three high-sensitivity (hs) methods in apparently healthy volunteers and patients admitted to emergency department (ED) with acute coronary syndrome enrolled in a large multicentre study. METHODS: Heparinized plasma samples were collected from 1511 apparently healthy subjects from 8 Italian clinical institutions (mean age: 51.5 years, SD: 14.1 years, range: 18-65 years, F/M ratio:0.95). All volunteers denied chronic or acute diseases and had normal values of routine laboratory tests. Moreover, 1322 heparinized plasma sample were also collected by 9 Italian clinical institutions from patients admitted to ED with clinical symptoms typical of acute coronary syndrome. The reference study laboratory assayed all plasma samples with three hs-methods: Architect hs-cTnI, Access hs-cTnI and ADVIA Centaur XPT methods. Principal Component Analysis (PCA) was also used to analyze the between-method differences among hs-cTnI assays. RESULTS: On average, a between-method difference of 31.2% CV was found among the results of hs-cTnI immunoassays. ADVIA Centaur XPT method measured higher cTnI values than Architect and Access methods. Moreover, 99th percentile URL values depended not only on age and sex of reference population, but also on the statistical approach used for calculation (robust non-parametric vs bootstrap). CONCLUSIONS: Due to differences in concentrations and reference values, clinicians should be advised that plasma samples of the same patient should be measured for cTnI assay in the same laboratory. Specific clinical studies are needed to establish the most appropriate statistical approach to calculate the 99th percentile URL values for hs-cTnI methods.
Clerico et al. (Thu,) conducted a observational in Healthy volunteers and acute coronary syndrome (n=2,833). Three high-sensitivity cTnI methods (Architect, Access, ADVIA Centaur XPT) was evaluated on Between-method differences among hs-cTnI assays. Comparison of three high-sensitivity cTnI immunoassays revealed an average between-method difference of 31.2% CV, with ADVIA Centaur XPT measuring higher values than Architect and Access methods.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: